Russell Frank Company’s Pfizer PFE Stock Holding History

Russell Frank Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$561M	Buy	19,944,761 +890,102	+5%	+$25.4M	0.99%	5
2015 Q4	$592M	Buy	19,054,659 +4,110,186	+28%	+$129M	1.03%	4
2015 Q3	$445M	Sell	14,944,473 -2,579,859	-15%	-$82.7M	0.83%	8
2015 Q2	$558M	Buy	17,524,332 +1,848,905	+12%	+$60.3M	0.89%	8
2015 Q1	$517M	Sell	15,675,427 -3,265,890	-17%	-$104M	0.95%	7
2014 Q4	$564M	Sell	18,941,317 -1,297,928	-6%	-$37.2M	0.99%	7
2014 Q3	$568M	Sell	20,239,245 -1,183,840	-6%	-$33.2M	1.01%	7
2014 Q2	$585M	Buy	21,423,085 +2,268,278	+12%	+$64.7M	1.02%	5
2014 Q1	$584M	Sell	19,154,807 -662,104	-3%	-$19.7M	1.03%	4
2013 Q4	$577M	Sell	19,816,911 -1,098,524	-5%	-$32M	1.06%	5
2013 Q3	$570M	Sell	20,915,435 -1,138,272	-5%	-$31M	1%	5
2013 Q2	$586M	Buy	+22,053,707	New	+$609M	1.07%	5

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Russell Frank Company's PFE Position: Q1 2016 in Review

Russell Frank Company increased its Pfizer (PFE) stake by 4.7% in Q1 2016, buying an estimated $25.4M and bringing the position to 19,944,761 shares worth $561M. The position accounts for 0.99% of the portfolio, ranked #5.

Russell Frank Company first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $592M in Q4 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Russell Frank Company held 19,944,761 shares of Pfizer worth $561M as of Q1 2016.
Russell Frank Company bought 890,102 Pfizer shares in Q1 2016, an estimated $25.4M.
Pfizer made up 0.99% of Russell Frank Company's portfolio in Q1 2016, its #5 holding.
Russell Frank Company first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Pfizer position peaked at $592M in Q4 2015.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.